Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.37 | -0.84% | -0.02 |
ABOS closed down 0.84 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | -0.84% | |
| NR7 | Range Contraction | -0.84% | |
| Lower Bollinger Band Walk | Weakness | -0.84% | |
| Wide Bands | Range Expansion | -0.84% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| Down 2 % | about 18 hours ago |
| Down 1% | about 18 hours ago |
| Possible NR7 | about 18 hours ago |
| Rose Above Previous Day's High | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Treatment Of Alzheimer's Amyloid Beta Targeted Immunotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Treatment Of Alzheimer's Amyloid Beta Targeted Immunotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.09 |
| 52 Week Low | 2.08 |
| Average Volume | 192,794 |
| 200-Day Moving Average | 3.06 |
| 50-Day Moving Average | 2.61 |
| 20-Day Moving Average | 2.81 |
| 10-Day Moving Average | 2.69 |
| Average True Range | 0.22 |
| RSI (14) | 40.12 |
| ADX | 26.84 |
| +DI | 19.17 |
| -DI | 24.60 |
| Chandelier Exit (Long, 3 ATRs) | 2.70 |
| Chandelier Exit (Short, 3 ATRs) | 2.89 |
| Upper Bollinger Bands | 3.42 |
| Lower Bollinger Band | 2.21 |
| Percent B (%b) | 0.13 |
| BandWidth | 42.95 |
| MACD Line | -0.07 |
| MACD Signal Line | 0.02 |
| MACD Histogram | -0.0928 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.57 | ||||
| Resistance 3 (R3) | 2.57 | 2.51 | 2.53 | ||
| Resistance 2 (R2) | 2.51 | 2.46 | 2.51 | 2.52 | |
| Resistance 1 (R1) | 2.44 | 2.43 | 2.41 | 2.44 | 2.51 |
| Pivot Point | 2.38 | 2.38 | 2.37 | 2.38 | 2.38 |
| Support 1 (S1) | 2.31 | 2.33 | 2.28 | 2.31 | 2.23 |
| Support 2 (S2) | 2.25 | 2.30 | 2.25 | 2.22 | |
| Support 3 (S3) | 2.18 | 2.25 | 2.21 | ||
| Support 4 (S4) | 2.18 |
